SECTORAL ASSET MANAGEMENT INC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 396 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.68 and the average weighting 0.3%.

Quarter-by-quarter ownership
SECTORAL ASSET MANAGEMENT INC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,182,687
-63.7%
18,006
-65.7%
0.42%
-57.5%
Q2 2023$6,006,460
+76.4%
52,449
+112.3%
1.00%
+52.8%
Q1 2023$3,405,779
+838.7%
24,710
+782.5%
0.66%
+835.7%
Q4 2022$362,824
+17.0%
2,8000.0%0.07%
+14.8%
Q3 2022$310,000
+47.6%
2,8000.0%0.06%
+45.2%
Q2 2022$210,000
-98.6%
2,800
-96.8%
0.04%
-96.0%
Q4 2020$14,769,000
+14.0%
86,624
-6.1%
1.04%
-6.6%
Q3 2020$12,958,000
-7.9%
92,274
+5.1%
1.11%
-13.8%
Q2 2020$14,074,000
+13.5%
87,774
-30.8%
1.29%
-45.7%
Q1 2020$12,400,000
+69.3%
126,759
+123.3%
2.38%
+117.7%
Q4 2019$7,324,000
+15.2%
56,760
-32.7%
1.09%
-0.4%
Q3 2019$6,357,000
-64.3%
84,398
-27.9%
1.10%
-48.4%
Q2 2019$17,793,000
+16.5%
117,097
-8.6%
2.13%
+15.9%
Q1 2019$15,268,000
+250.1%
128,098
+374.4%
1.84%
+296.5%
Q3 2018$4,361,000
-84.0%
27,000
-86.9%
0.46%
-84.8%
Q2 2018$27,189,000
+12.0%
205,699
-37.2%
3.04%
+14.2%
Q1 2018$24,279,000
+82.6%
327,698
+37.1%
2.66%
+60.2%
Q4 2017$13,298,000
+324.3%
238,999
+245.9%
1.66%
+311.4%
Q3 2017$3,134,000
+222.8%
69,099
+139.9%
0.40%
+281.1%
Q2 2017$971,000
+14.0%
28,7990.0%0.11%
+7.1%
Q1 2017$852,000
+7.8%
28,7990.0%0.10%
+12.5%
Q4 2016$790,00028,7990.09%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders